Establishment and validation of a nomogram to predict thirty-day unplanned reoperations of primary anastomosis in neonates with intestinal atresias

建立和验证预测新生儿肠闭锁一期吻合术后30天内非计划再次手术的列线图

阅读:1

Abstract

BACKGROUND/PURPOSE: Unplanned reoperation rates becoming a critical metric for evaluating healthcare quality and have received increasing attention in recent years. Intestinal atresia (IA) has a high rate of unplanned reoperations. The purpose of this study is to evaluate the thirty-day unplanned reoperation rates and their risk factors in neonates with intestinal atresias after primary anastomosis surgery, and to construct a predictive nomogram. METHODS: We developed and internally validated a predictive model from a retrospective cohort of 200 neonates admitted to our hospital for primary anastomosis surgery. The primary outcome was thirty-day unplanned reoperation rates. Independent factors significantly associated with thirty-day unplanned reoperation rates were identified using multivariable logistic regression analysis. The effectiveness of the developed nomogram was evaluated through calibration, discrimination, and clinical utility. RESULTS: The incidence of thirty-day unplanned reoperation rates was 11%. Multivariable analysis identified the type of bowel anastomosis and combined meconium peritonitis as independent factors predicting thirty-day unplanned reoperation rates. The derivation model showed good discrimination, with a C-index of 0.791 (95% CI, 0.685-0.897), and good calibration (Hosmer-Lemeshow test P = 0.231). The analysis of the decision curve showed that the nomogram was beneficial in clinical practice. CONCLUSION: We developed a nomogram to predict thirty-day unplanned reoperations of primary anastomosis in neonates with IA. This prediction model may enable assist in clinical decision-making, patient counseling, and treatment planning.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。